Surgida como spinoff del Instituto Murciano de Investigación Biosanitaria (IMIB), abre así una nueva etapa en la que se ampliará el equipo científico y de gestión, y se avanzará en la producción de su prototipo, previsto para finales de 2023 Murcia se ha convertido en un polo de desarrollo de proyectos de innovación biosanitaria en los últimos […]
The Ship2B Foundation has communicated to the biomedical company Viva In Vitro on this February 15.— “After going through the Impact recognition process, the Ship2B Foundation is pleased to send you the recognition that accredits Viva in Vitro as an Impact Business 2023 initiative, under the criteria of the Ship2B Foundation which has been
Viva in Vitro, ‘spin off’ del Hospital Clínico Universitario Virgen de la Arrixaca, la Universidad de Murcia y el instituto mur- ciano de Investigación Biosanitaria, ha puesto sus miras en la sepsis, primera causa de muerte hospitalaria. Según la OMS esta patología afecta cada año a más de 50 millones de personas…..
Noticia en Expansión ‘Start up’ que pasan del laboratorio a la empresa Read More »
Viva In Vitro Diagnostics CEO considers it essential to create an association of biotechnology companies in the Region.
Welcome to our news page. After years of work and dedication to give this project a corporate shape, Pablo Pelegrín, Carlos García-Palenciano, María Fuensanta-Martínez, on behalf of the FFIS, Joaquín Gómez-Moya and a group of researchers from the IMIB and doctors from the Virgen de la Arrixaca Hospital founded Viva In Vitro Diagnostics L.L.C. in
During the Somos Equipo event, regional president Fernando López-Miras recognized the leaders of the regional economic transformation towards a Knowledge Economy in accordance with the RIS3MUR strategy. In the course of the act also intervened the Regional Minister of Economy, the General Manager of the INFO and the well-known economist Marc Vidal. In the photograph,
Subscribe to VIVA Insights: The leading newsletter on inflammasomes and sepsis
Receive exclusive analysis, scientific breakthroughs and collaboration opportunities from our network of international partners and benchmarks.
